Adm Tronics Unlimited, Inc. ADMT

Q1 FY2026 · ended Jun 30, 2026 · Revenue $866,255, -11.0% YoY · Filed Aug 19, 2026

Adm Tronics Unlimited, Inc. (ADMT) files with the SEC under industry code 3845, Electromedical & Electrotherapeutic Apparatus. In Q1 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $866,255 and net income of $32,364. As of Jun 30, 2026 it held $597,619 in cash and investments and $203,848 in total debt.

Revenue
$866,255
-11.0% vs year-ago quarter
Net income
$32,364
-90.1% vs year-ago quarter
Operating cash flow
$-32,959
-122.7% vs year-ago quarter
Free cash flow
—
EPS
$0.00
Dividend per share
None
Shares outstanding
67.59M
+0.0% vs year-ago quarter
Net cash
$393,771
Q1 FY2026
Operating margin
-7.2%
TTM

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
ADMT (OTC)
Fiscal year ends
March 31
Incorporated in
DE
Headquarters
Northvale, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
849401
Former names
ADM TRONICS UNLIMITED INC/DE (until Jul 17, 2015)

Other Electromedical & Electrotherapeutic Apparatus companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q1 FY2026
Jun 30, 2026
Q4 FY2026
Mar 31, 2026
Q3 FY2026
Dec 31, 2025
Q2 FY2025
Sep 30, 2025
Q1 FY2025
Jun 30, 2025
Revenue
$866,255
$682,821
$803,088
$887,498
$973,675
Operating income
-$20,655
-$186,443
-$84,441
$2,553
$109,234
Net income
$32,364
-$198,480
-$114,856
-$114,672
$327,634
Diluted EPS
—
—
$0.00
—
—
Operating cash flow
-$32,959
-$41,244
-$82,815
-$63,282
-$14,800
Total assets
$2.0M
$1.8M
$2.1M
$2.2M
$2.4M
Total liabilities
$1.4M
$1.3M
$1.3M
$1.3M
$1.4M
Stockholders' equity
$603,336
$570,972
$761,211
$880,424
$995,096
Cash and investments
$597,619
$570,730
$613,733
$661,724
$821,290
Total debt
$203,848
$227,928
$251,710
$280,419
$298,393

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Regulation FD disclosure
Oct 30, 2026 Oct 26, 2026
10-Q Quarterly report Aug 19, 2026 Jun 30, 2026
10-K Annual report Jul 10, 2026 Mar 31, 2026
10-Q Quarterly report Feb 13, 2026 Dec 31, 2025
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
10-Q Quarterly report Aug 19, 2025 Jun 30, 2025

Source: SEC EDGAR filings. This is company-reported data, not investment advice.